Goldman Sachs Group Inc Mirati Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $1.69 Million - $2.51 Million	40,234 Added 114.96%	75,233 $4.42 Million
Q3 2023 May 14, 2024	SELL	$27.8 - $45.35 $1.12 Million - $1.82 Million	-40,234 Reduced 53.48%	34,999 $1.52 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $171,136 - $279,174	-6,156 Reduced 14.96%	34,999 $1.52 Million
Q2 2023 May 14, 2024	SELL	$36.13 - $49.49 $238,710 - $326,980	-6,607 Reduced 13.83%	41,155 $1.49 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $238,710 - $326,980	-6,607 Reduced 13.83%	41,155 $1.49 Million
Q1 2023 May 14, 2024	SELL	$36.54 - $54.26 $8.95 Million - $13.3 Million	-244,936 Reduced 83.68%	47,762 $1.78 Million
Q1 2023 May 11, 2023	SELL	$36.54 - $54.26 $8.95 Million - $13.3 Million	-244,936 Reduced 83.68%	47,762 $1.78 Million
Q4 2022 May 14, 2024	BUY	$41.27 - $98.62 $3.07 Million - $7.34 Million	74,440 Added 34.11%	292,698 $13.3 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $3.07 Million - $7.34 Million	74,440 Added 34.11%	292,698 $13.3 Million
Q3 2022 May 14, 2024	SELL	$59.5 - $86.7 $133 Million - $193 Million	-2,229,202 Reduced 91.08%	218,258 $15.2 Million
Q3 2022 Nov 10, 2022	SELL	$59.5 - $86.7 $133 Million - $193 Million	-2,229,202 Reduced 91.08%	218,258 $15.2 Million
Q2 2022 May 14, 2024	BUY	$39.16 - $88.71 $92.9 Million - $210 Million	2,372,227 Added 3153.17%	2,447,460 $164 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $90.8 Million - $206 Million	2,318,853 Added 1803.05%	2,447,460 $164 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $7.92 Million - $15.8 Million	-104,492 Reduced 44.83%	128,607 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $4.87 Million - $7.02 Million	36,903 Added 18.81%	233,099 $34.2 Million
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $25.9 Million - $34.8 Million	196,196 New	196,196 $34.7 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account